PrognomiQ
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1900 Alameda De Las Pulgas Ste 100, San ...Phone Number
(650) 750-2447Website
www.prognomiq.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About PrognomiQ
PrognomiQ is developing transformative test products that enable early disease detection and treatment. We do this by generating proprietary proteomic data at unparalleled volumes and depth of information. We then complement this extensive proteomic information with genomic, metabolomic, and other health data to discover innovative approaches to early disease detection that translate into transformative test products.Explore more
PrognomiQ Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PrognomiQ your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on PrognomiQ recently announced quarterly report
Product Launch: Get notified when PrognomiQ launches new products
Click to see if PrognomiQ had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once PrognomiQ has new funding data
Check out if PrognomiQ is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at PrognomiQ
PrognomiQ, which may be a good buyer, showed buying intent in Masked Content Topic
Check if PrognomiQ has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined PrognomiQ as Masked Content
Find more new buyers
Compare Similar Companies to PrognomiQ
Compare insights from companies similar to PrognomiQ, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PrognomiQ is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PrognomiQ is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PrognomiQ.
PrognomiQ financials insights
Gather financial insights about PrognomiQ, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$46M
2024
Series D
$34M
2025
Private Equity
$10.1M
PrognomiQ Tech Stack
A closer look at the technologies used by PrognomiQ
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
PrognomiQ News & Media
UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.PrognomiQ Appoints Joel Kaufman as Chief Financial Officer - GlobeNewswire
PrognomiQ Announces the appointment of Joel Kaufman as Chief Financial Officer, serving on the company's Executive Team. ...PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PrognomiQ
Sign Up For FreeTo access detailed company insights
PrognomiQ is developing transformative test products that enable early disease detection and treatment. We do this by generating proprietary proteomic data at unparalleled volumes and depth of information. We then complement this extensive proteomic information with genomic, metabolomic, and other health data to discover innovative approaches to ea... Read More
